Dr. MiltieAtlas by Dr. Miltie™Nationwide Grant Intelligence
Verification Pending — official Grants.gov candidate (posted)
RFA-HG-27-013

GREGoRi Innovation Projects (U01 Clinical Trial Optional)

Official Grants.gov opportunity RFA-HG-27-013 from National Institutes of Health. Requires full eligibility, amount, controlling deadline, award-type and duplication QA before publication.

FundingOfficial federal synopsis lists an award ceiling of 500,000; applicant-level applicability requires full-NOFO review.
Deadline2026-10-30 (official deadline clock time and time zone must be checked in NOFO)
Last verifiedAtlas review
Required next actionReview the official full announcement, amendments and submission portal requirements before applying.

Broad Eligibility

Private institutions of higher education; Independent school districts; County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments; Public and State controlled institutions of higher education; Small businesses; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; State governments; City or township governments

Official funding announcement — preliminary draft

Funder: National Institutes of Health

Opportunity number: RFA-HG-27-013

Official listed status: posted

Closing information: 2026-10-30 (official deadline clock time and time zone must be checked in NOFO)

Award disclosure: Official federal synopsis lists an award ceiling of 500,000; applicant-level applicability requires full-NOFO review.

Applicant categories in federal synopsis: Private institutions of higher education; Independent school districts; County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments; Public and State controlled institutions of higher education; Small businesses; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; State governments; City or township governments

Federal synopsis

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.

Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.

Official Grants.gov opportunity and NOFO

From Funding to Implementation · School Health Solution

Turn school-health funding into a clinically capable care model.

Dr. Miltie N9+ can support clinician-directed remote exams in school settings, helping care teams move beyond video-only encounters when a funded program calls for stronger pediatric access.

Explore School-Based Virtual Exams ↗Dr. Miltie solves the healthcare problem. Atlas helps fund the solution.
Source verificationOfficial government source · www.grants.govAtlas last verified this record during its latest review. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗